[(3S)-3,5-dihydroxypentyl] 4-methylbenzenesulfonate | 189163-23-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [(3S)-3,5-dihydroxypentyl] 4-methylbenzenesulfonate
• CAS: 189163-23-3
• 化学式: C₁₂H₁₈O₅S
• 分子量: 274.338
• InChiKey: HPYACLYQWXZQBS-NSHDSACASA-N

物化性质

• 沸点：
  477.6±40.0 °C(Predicted)
• 密度：
  1.274±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  92.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [(3S)-3,5-dihydroxypentyl] 4-methylbenzenesulfonate 在 4-二甲氨基吡啶 、 lithium aluminium tetrahydride 、 正丁基锂 、 四丁基氟化铵 、 sodium hydride 、 N,N-二异丙基乙胺 、 sodium iodide 作用下， 以 四氢呋喃 、 二氯甲烷 、 二乙二醇二甲醚 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 101.0h， 生成 (E,3R,11R)-3-methoxydodec-6-ene-1,11-diol
  参考文献：
  名称：

  Total Synthesis of Dolatrienoic Acid:  A Subunit of Dolastatin 14

  摘要：

  The (7R,15R)- and (7S,15R)-diastereomers of dolatrienoic acid were synthesized using a convergent strategy. Fragment C5-C9 was obtained through enantiodifferentiation of racemic pentane-1,3,5-triol as the key step, fixing the chirality at C7 of fragments 4 and ent-4. The chirality at C15 of the fragment C10-C16 was introduced from L-glutamic acid. Coupling of these two fragments led to the aldehydes (7R,15R)- and (7S,15R)-2 which were homologated by Horner-Wadsworth-Emmons condensation to give (7R,15R)- and (7S,15R)-dolatrienoic acids.

  DOI：

  10.1021/jo962217a
• 作为产物：
  描述：

  1,3,5-戊三醇 在 盐酸 、 4-二甲氨基吡啶 、 sodium hydroxide 、 silica gel 、 对甲苯磺酸 、 原甲酸三甲酯 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 生成 [(3S)-3,5-dihydroxypentyl] 4-methylbenzenesulfonate
  参考文献：
  名称：

  Total Synthesis of Dolatrienoic Acid:  A Subunit of Dolastatin 14

  摘要：

  The (7R,15R)- and (7S,15R)-diastereomers of dolatrienoic acid were synthesized using a convergent strategy. Fragment C5-C9 was obtained through enantiodifferentiation of racemic pentane-1,3,5-triol as the key step, fixing the chirality at C7 of fragments 4 and ent-4. The chirality at C15 of the fragment C10-C16 was introduced from L-glutamic acid. Coupling of these two fragments led to the aldehydes (7R,15R)- and (7S,15R)-2 which were homologated by Horner-Wadsworth-Emmons condensation to give (7R,15R)- and (7S,15R)-dolatrienoic acids.

  DOI：

  10.1021/jo962217a

文献信息

• N-substituted piperidine derivatives as serotonin receptor agents
  申请人：Andersson Carl-Magnus

  公开号：US20060094758A1

  公开（公告）日：2006-05-04

  Disclosed herein are compounds of Formula I, or a pharmaceutically acceptable salt, amide, ester, or prodrug thereof. Also disclosed are methods of inhibiting an activity of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Disclosed are also methods of inhibiting an activation of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Furthermore, methods of treating psychotic disease using a compound of Formula I are disclosed.

  本文披露了公式I的化合物，或其药学上可接受的盐、酰胺、酯或前药。还披露了抑制单胺受体活性的方法，包括将单胺受体或含有单胺受体的系统与公式I的一种或多种化合物的有效量接触。还披露了抑制单胺受体激活的方法，包括将单胺受体或含有单胺受体的系统与公式I的一种或多种化合物的有效量接触。此外，本文还披露了使用公式I的化合物治疗精神疾病的方法。
• USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS
  申请人：van Kammen Daniel

  公开号：US20080051429A1

  公开（公告）日：2008-02-28

  Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.

  揭示了逆向激动剂和拮抗剂的血清素受体，用于治疗睡眠障碍，如失眠，特别是睡眠维持失眠。该化合物增加慢波睡眠，减少入睡后醒来的次数，减少入睡后清醒的时间。
• N-SUBSTITUTED PIPERIDINE DERIVATIVES AS SEROTONIN RECEPTOR AGENTS
  申请人：Acadia Pharmaceuticals Inc.

  公开号：EP1562937A2

  公开（公告）日：2005-08-17
• US7253186B2
  申请人：——

  公开号：US7253186B2

  公开（公告）日：2007-08-07
• US7476682B2
  申请人：——

  公开号：US7476682B2

  公开（公告）日：2009-01-13